|
KALV Kalvista Pharmaceuticals Inc 1348911 |
| Balance Sheet |
|
Current Assets
|
152,267,000 |
|
Assets
|
160,831,000 |
|
Current Liabilities
|
22,164,000 |
|
Liabilities
|
26,839,000 |
|
Equity
|
133,992,000 |
|
Shares Out
|
43,215,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-79,862,000 |
|
Investing Cash Flow
|
85,835,000 |
| Market Analysis |
Market Cap
|
464,566,195 |
|
Price
|
8.30 |
|
BVPS
|
3.10 |
|
PB
|
2.67 |
|
EPS
|
-3.54 |
|
PS
|
0.86 |
|
FCF
|
5,973,000 |
|
| Earnings |
|
| Jul |
Aug |
Sep |
| 7/11 |
-1.02 |
|
|
9/05 |
-0.87 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view KALV documents filed with the SEC.
KALV Filings
Clear
